Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.290,96
-0,57%
NASDAQ
16.722,45
-0,65%
Bitcoin
69.608,86
-0,74%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avalon GloboCare Corporation (AVCO) Avalon GloboCare Corporation (AVCO) Notizie

AVCO

Avalon GloboCare (AVCO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVCO
DataOraFonteTitoloSimboloCompagnia
29/06/202322:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AVCOAvalon GloboCare Corporation
29/06/202312:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVCOAvalon GloboCare Corporation
26/05/202323:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVCOAvalon GloboCare Corporation
26/05/202313:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVCOAvalon GloboCare Corporation
22/05/202322:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVCOAvalon GloboCare Corporation
16/05/202314:58Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AVCOAvalon GloboCare Corporation
30/03/202322:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVCOAvalon GloboCare Corporation
23/03/202311:04Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:AVCOAvalon GloboCare Corporation
09/03/202317:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVCOAvalon GloboCare Corporation
12/12/202216:41Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVCOAvalon GloboCare Corporation
21/11/202222:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVCOAvalon GloboCare Corporation
14/11/202222:51Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)NASDAQ:AVCOAvalon GloboCare Corporation
09/11/202222:00GlobeNewswire Inc.Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”NASDAQ:AVCOAvalon GloboCare Corporation
08/11/202215:10GlobeNewswire Inc.Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 MillionNASDAQ:AVCOAvalon GloboCare Corporation
29/09/202215:00GlobeNewswire Inc.Avalon GloboCare Receives Allowance for Joint U.S. PatentNASDAQ:AVCOAvalon GloboCare Corporation
08/08/202215:00GlobeNewswire Inc.Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical SocietyNASDAQ:AVCOAvalon GloboCare Corporation
28/07/202212:09BenzingaWhy Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving PremarketNASDAQ:AVCOAvalon GloboCare Corporation
25/05/202215:00GlobeNewswire Inc.Avalon GloboCare to Present at the Jefferies 2022 Healthcare ConferenceNASDAQ:AVCOAvalon GloboCare Corporation
18/05/202215:00GlobeNewswire Inc.Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular TherapyNASDAQ:AVCOAvalon GloboCare Corporation
27/04/202215:00GlobeNewswire Inc.Avalon GloboCare Expands IP Portfolio; Files 16 New Patent ApplicationsNASDAQ:AVCOAvalon GloboCare Corporation
14/02/202215:00GlobeNewswire Inc.Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell TherapiesNASDAQ:AVCOAvalon GloboCare Corporation
04/01/202215:00GlobeNewswire Inc.Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical ProgramsNASDAQ:AVCOAvalon GloboCare Corporation
22/12/202115:00GlobeNewswire Inc.Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to MarketNASDAQ:AVCOAvalon GloboCare Corporation
09/12/202115:00GlobeNewswire Inc.Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy DevelopmentNASDAQ:AVCOAvalon GloboCare Corporation
07/12/202115:04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:AVCOAvalon GloboCare Corporation
14/10/202115:20GlobeNewswire Inc.Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular ImmunotherapyNASDAQ:AVCOAvalon GloboCare Corporation
07/10/202115:00GlobeNewswire Inc.Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related DiseasesNASDAQ:AVCOAvalon GloboCare Corporation
23/09/202115:00GlobeNewswire Inc.Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30thNASDAQ:AVCOAvalon GloboCare Corporation
13/09/202115:30GlobeNewswire Inc.Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of DirectorsNASDAQ:AVCOAvalon GloboCare Corporation
04/08/202115:00GlobeNewswire Inc.UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCareNASDAQ:AVCOAvalon GloboCare Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVCO

La tua Cronologia

COIN
RUPLGBP
Indian Rupee
ASX
PLAR
NASDAQ
FSNM
First State Bancorporation
EU
9414T
9414T
BOV
PDTC3M
Padtec ON
BIT
P1RAC1
BNP Paribas Issuance
USOTC
FSRCY
First Resources (PK)
BMF
FRCF30
FRCF30 - 01/2030
NASDAQ
FMIMSX
Income Dividend Equity A...
COIN
ALCAZARUSD
Alcazar
BIT
P1IAN7
BNP Paribas Issuance
NASDAQ
ZFOX
ZeroFox
EU
MWRD
Amundi Index Solutions
POLO
POLISUSDT
Star Atlas DAO
NYSE
KYN
Kayne Anderson Energy In...
TSXV
RPN
Red Pine Petroleum
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network